Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin.
D000230:Adenocarcinoma / Q000276:immunology; D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000276:immunology; D000328:Adult; D000368:Aged; D002277:Carcinoma / Q000276:immunology; D002283:Carcinoma, Bronchogenic / Q000276:immunology*; D018288:Carcinoma, Small Cell / Q000276:immunology; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D005260:Female; D006801:Humans; D037102:Lectins / Q000494:pharmacology*; D008175:Lung Neoplasms / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects*; D008214:Lymphocytes / Q000187:drug effects* / Q000276:immunology; D008297:Male; D008722:Methods; D008875:Middle Aged; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D037102:Lectins; D014316:Tritium; D013936:Thymidine